Overview
Ebastine is under investigation for the treatment of Irritable Bowel Syndrome (IBS). Ebastine has been investigated for the treatment of Urticaria.
Indication
用于伴有或不伴有过敏性结膜炎的过敏性鼻炎（季节性和常年性）。慢性特发性荨麻疹的对症治疗。
Associated Conditions
- Allergic Rhinitis (AR)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/04/18 | Phase 3 | Recruiting | Guy Boeckxstaens | ||
2013/09/12 | Phase 4 | Completed | Grupo de Alergología Clínica y Experimental | ||
2013/07/25 | Phase 4 | Completed | |||
2010/06/16 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| KESTINE TABLET 10 mg | SIN09435P | TABLET, FILM COATED | 10.00mg | 7/31/1997 | |
| KESTINE FILM-COATED TABLET 20MG | SIN15644P | TABLET, FILM COATED | 20.0mg | 3/12/2019 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Ebastine Oral Solution | 国药准字H20243410 | 化学药品 | 口服溶液剂 | 3/29/2024 | |
| Ebastine Oral Solution | 国药准字H20253789 | 化学药品 | 口服溶液剂 | 4/1/2025 | |
| Ebastine Oral Solution | 国药准字H20249219 | 化学药品 | 口服溶液剂 | 10/29/2024 | |
| Ebastine Oral Solution | 国药准字H20243051 | 化学药品 | 口服溶液剂 | 1/16/2024 | |
| Ebastine Oral Solution | 国药准字H20254099 | 化学药品 | 口服溶液剂 | 5/13/2025 | |
| Ebastine Tablets | 国药准字HJ20140856 | 化学药品 | 片剂 | 11/30/2023 | |
| Ebastine Tablets | 国药准字H20040503 | 化学药品 | 片剂 | 4/30/2020 | |
| Ebastine Tablets | 国药准字HJ20140855 | 化学药品 | 片剂 | 11/30/2023 | |
| Ebastine Tablets | 国药准字H20040119 | 化学药品 | 片剂 | 8/10/2020 | |
| Ebastine Tablets | 国药准字H20249121 | 化学药品 | 片剂 | 10/22/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.